This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Eurand Announces Pricing of Offering of Ordinary Shares 2009-10-22 09:30 ET - News Release AMSTERDAM, THE NETHERLANDS
-- (MARKET WIRE)
-- 10/22/09 
Eurand N.V. (NASDAQ: EURX), a
global specialty pharmaceutical company, today announced the pricing of its
previously disclosed public offering of 8,500,000 ordinary shares at an
initial price to the public of $11.25 per share. The shares are being
offered through an underwriting syndicate led by Deutsche Bank Securities
and BofA Merrill Lynch, together with co-managers Cowen and Company and
Thomas Weisel Partners. The offering is expected to close on or about
October 27, 2009.
Of the 8,500,000 shares being offered, 2,000,000 are newly issued by Eurand
N.V., and the remaining 6,500,000 are currently issued and outstanding. The
Company intends to use the net proceeds from the sale of its 2,000,000
ordinary shares to fund potential product acquisitions and/or potential
acquisitions of complementary businesses and research and development of
additional product candidates, as well as to fund working capital and other
general corporate purposes.
The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page